These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16541187)

  • 21. Hyperprolactinemia: pathophysiology and therapeutic approach.
    Capozzi A; Scambia G; Pontecorvi A; Lello S
    Gynecol Endocrinol; 2015 Jul; 31(7):506-10. PubMed ID: 26291795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.
    Lee BH; Kim YK; Park SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):714-7. PubMed ID: 16571367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
    Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
    J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prolactin and the laboratory].
    Veloza A; Prazeres S
    Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
    Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
    J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital.
    Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P
    J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of hyperprolactinemia and acromegaly with lisuride].
    Berezin M; Elchalal U; Olchovsky D
    Harefuah; 1989 Jun; 116(12):634-7. PubMed ID: 2792946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperprolactinaemia caused by antipsychotic drugs: a new application for prolactin assays.
    Ellis A; Fahie-Wilson M
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):287-9. PubMed ID: 20592330
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK; Huang YS; Ree SC; Hsiao CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Verapamil-induced hyperprolactinemia--a case report].
    Krysiak R; Okopieh B; Herman ZS
    Pol Arch Med Wewn; 2005 Feb; 113(2):155-8. PubMed ID: 16209236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cabergoline: long-acting oral treatment of hyperprolactinemic disorders.
    Ferrari C; Mattei A; Melis GB; Paracchi A; Muratori M; Faglia G; Sghedoni D; Crosignani PG
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1201-6. PubMed ID: 2656736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of hyperprolactinemia: determination of prolactin level at rest].
    Ishay A; Luboshitzky R
    Harefuah; 1998 Nov; 135(9):348-50, 408, 407. PubMed ID: 10911442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: CLINICAL RELEVANCE OF MACROPROLACTIN IN THE ABSENCE OR PRESENCE OF TRUE HYPERPROLACTINEMIA.
    Samson SL; Hamrahian AH; Ezzat S; ;
    Endocr Pract; 2015 Dec; 21(12):1427-35. PubMed ID: 26642103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The diagnosis of hyperprolactinemia in clinical practice].
    Lech MM
    Ginekol Pol; 2005 Dec; 76(12):1008-13. PubMed ID: 16566383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperprolactinemia].
    Molinatti GM; Limone P
    Minerva Med; 1991; 82(7-8):423-39. PubMed ID: 1922887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperprolactinemia and bone.
    di Filippo L; Doga M; Resmini E; Giustina A
    Pituitary; 2020 Jun; 23(3):314-321. PubMed ID: 32219718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Importance of prolactin isoforms on ovary function in hyperprolactinemic women].
    Romero C; León J; Jara R; González O
    Rev Chil Obstet Ginecol; 1993; 58(6):465-9. PubMed ID: 7991872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.
    Yasui-Furukori N; Furukori H; Sugawara N; Fujii A; Kaneko S
    J Clin Psychopharmacol; 2010 Oct; 30(5):596-9. PubMed ID: 20814333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Macroprolactinemia. Risk of misdiagnosis and mismanagement in hyperprolactinemia].
    Valdemarsson S
    Lakartidningen; 2004 Feb; 101(6):458-65. PubMed ID: 15004940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.